162 related articles for article (PubMed ID: 10710533)
1. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.
Atochina EN; Beers MF; Scanlon ST; Preston AM; Beck JM
Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L599-609. PubMed ID: 10710533
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice.
Beers MF; Atochina EN; Preston AM; Beck JM
J Lab Clin Med; 1999 May; 133(5):423-33. PubMed ID: 10235125
[TBL] [Abstract][Full Text] [Related]
4. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.
Wright TW; Notter RH; Wang Z; Harmsen AG; Gigliotti F
Infect Immun; 2001 Feb; 69(2):758-64. PubMed ID: 11159965
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.
Wang Z; Foye A; Chang Y; Chess PR; Wright TW; Bhagwat S; Gigliotti F; Notter RH
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1124-31. PubMed ID: 15886399
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.
Phelps DS; Umstead TM; Rose RM; Fishman JA
Eur Respir J; 1996 Mar; 9(3):565-70. PubMed ID: 8730021
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid.
Sternberg RI; Whitsett JA; Hull WM; Baughman RP
J Lab Clin Med; 1995 Apr; 125(4):462-9. PubMed ID: 7706901
[TBL] [Abstract][Full Text] [Related]
10. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
11. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
Zimmerman PE; Voelker DR; McCormack FX; Paulsrud JR; Martin WJ
J Clin Invest; 1992 Jan; 89(1):143-9. PubMed ID: 1530850
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice.
Fisher JH; Sheftelyevich V; Ho YS; Fligiel S; McCormack FX; Korfhagen TR; Whitsett JA; Ikegami M
Am J Physiol Lung Cell Mol Physiol; 2000 Feb; 278(2):L365-73. PubMed ID: 10666121
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
[TBL] [Abstract][Full Text] [Related]
14. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.
O'Riordan DM; Standing JE; Kwon KY; Chang D; Crouch EC; Limper AH
J Clin Invest; 1995 Jun; 95(6):2699-710. PubMed ID: 7769109
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice.
Hawgood S; Akiyama J; Brown C; Allen L; Li G; Poulain FR
Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1148-56. PubMed ID: 11350793
[TBL] [Abstract][Full Text] [Related]
17. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
Friedrich B; Schmidt R; Reiss I; Günther A; Seeger W; Müller M; Thul J; Schranz D; Gortner L
Crit Care Med; 2003 Jan; 31(1):284-90. PubMed ID: 12545030
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructure of phospholipid mixtures reconstituted with surfactant proteins B and D.
Poulain FR; Akiyama J; Allen L; Brown C; Chang R; Goerke J; Dobbs L; Hawgood S
Am J Respir Cell Mol Biol; 1999 May; 20(5):1049-58. PubMed ID: 10226076
[TBL] [Abstract][Full Text] [Related]
19. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.
Lesur O; Veldhuizen RA; Whitsett JA; Hull WM; Possmayer F; Cantin A; Bégin R
Lung; 1993; 171(2):63-74. PubMed ID: 8426464
[TBL] [Abstract][Full Text] [Related]
20. Intra-amniotic endotoxin increases pulmonary surfactant proteins and induces SP-B processing in fetal sheep.
Bachurski CJ; Ross GF; Ikegami M; Kramer BW; Jobe AH
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L279-85. PubMed ID: 11159007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
